PreprintAll rights reservedbioRxiv
TRPV4 antagonist efficacy in a post-hemorrhagic hydrocephalus pig model
- 1Indiana University Indianapolis
Related
- Therapeutic Potential of Melatonin, Erythropoietin, and TRPV4 Antagonism in a Preclinical Model of Genetic Hydrocephalus
- Finding the Goldilocks zone: modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
- Efficacy of rTMS in Post‐Stroke Bilingual Aphasia: A Single Case Experimental Design
- Phosphoproteomic Insights into TRPV4–AMPK Signaling Axis and Barrier Regulation in the Choroid Plexus Epithelium
- Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses
BibTeX
@misc{bentley2026trpv4,
title = {{TRPV4 antagonist efficacy in a post-hemorrhagic hydrocephalus pig model}},
author = {R. T. Bentley and S. C. Mitchell and R. R. McCain and G. T. Knipp and D. Audu and F. O. Bidgoli and A. L. Hochstetler and D. J. Behm and A. D. Cox and B. L. Blazer-Yost},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.02.763674},
url = {https://www.biorxiv.org/content/10.64898/2026.11.02.763674v1},
}
RIS
TY - UNPB
TI - TRPV4 antagonist efficacy in a post-hemorrhagic hydrocephalus pig model
AU - R. T. Bentley
AU - S. C. Mitchell
AU - R. R. McCain
AU - G. T. Knipp
AU - D. Audu
AU - F. O. Bidgoli
AU - A. L. Hochstetler
AU - D. J. Behm
AU - A. D. Cox
AU - B. L. Blazer-Yost
PY - 2026
DA - 2026/11/02
PB - bioRxiv
DO - 10.64898/2026.11.02.763674
UR - https://www.biorxiv.org/content/10.64898/2026.11.02.763674v1
ER -